|
|
 |
Gloomy tales rosuvastatin roswin 10 mg For 2013, the company raised its 2013 membership and profitforecasts to reflect the stronger-than-expected third quarterperformance. It now expects 2013 earnings of at least $8.40 pershare. Analysts had forecast $8.27.
2021-5-19 21:50:38 |
|
|
|
